Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Angela Consagra

2PUBLICATIONS

16CO-AUTHORS

Predictive and prognostic markersHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jun 25, 2025

IPSS-M risk and specific sex-associated somatic mutations predict response to ESA therapy in LR-MDS: building a new score.

Marco G Raddi, Sophie Park, Michaela Fontenay

|May 03, 2025

How to use luspatercept and erythropoiesis-stimulating agents in low-risk myelodysplastic syndrome.

Valeria Santini, Angela Consagra

Pageof 1

Frequent Collaborators

2 joint publications

Valeria Santini

1 joint publications

Marco Gabriele Gabriele Raddi

1 joint publications

Olivier Kosmider

1 joint publications

María Díez-Campelo

1 joint publications

Marie Sébert

1 joint publications

Lionel Adès

1 joint publications

Uwe Platzbecker

1 joint publications

Matteo G Della Porta

1 joint publications

Giorgio Mattiuz

1 joint publications

Sven Julien Maria De Pourcq

Frequent Collaborators

2 joint publications

Valeria Santini

1 joint publications

Marco Gabriele Gabriele Raddi

1 joint publications

Olivier Kosmider

1 joint publications

María Díez-Campelo

Top Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on : Aug 21, 2016

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on : Oct 03, 2018

See more related videos

Top Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on : Aug 21, 2016

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on : Oct 03, 2018

See more related videos